文献速递功能神经外科脑血管病外科

显微血管减压与经皮球囊压迫治疗椎基底动脉延长扩张症继发三叉神经痛的疗效分析:回顾性队列研究

Efficacy analysis of microvascular decompression and percutaneous balloon compression for trigeminal neuralgia secondary to vertebrobasilar dolichoectasia: a retrospective cohort study.
PubMed 文献 · Acta Neurochir (Wien) · 2025-08-21

该回顾性队列纳入2013年9月至2022年8月单中心107例椎基底动脉延长扩张症继发三叉神经痛患者,比较显微血管减压术(MVD,64例)与经皮球囊压迫(PBC,43例)的疗效。两组初始疼痛控制均良好,末次随访复发率分别为12.5%与20.9%(p=0.242),无统计学差异;PBC组早期面部麻木等三叉神经功能障碍及远期麻木评分更高,MVD组住院费用更高、住院时间更长且颅神经并发症更多样。

要点

  • MVD与PBC对VBD-TN均安全有效,末次随访复发率无统计学差异。
  • PBC组早期面部麻木、干眼及咀嚼肌无力发生率显著更高。
  • MVD组住院费用更高、住院时间更长且颅神经并发症更多样。

核心结论

  • MVD与PBC均为VBD-TN安全有效的治疗选择。
  • MVD与住院费用更高、住院时间更长及颅神经并发症发生率更高相关,但多数并发症可治疗。
  • PBC的主要缺点在于长期面部麻木。

研究设计与样本

  • 回顾性队列分析,纳入2013年9月至2022年8月中国一家三级医院的连续VBD-TN患者。
  • 共107例,平均年龄64.8±10.0岁,平均随访3.9±1.9年;MVD组64例,PBC组43例。
  • 按干预方式分层,系统评估术后疼痛控制疗效与并发症发生率。

主要发现

  • 两组初始疼痛控制均优(BNI疼痛评分I或II)。
  • 末次随访复发(BNI III、IV、V)率MVD组12.5%(8/64)对PBC组20.9%(9/43),p=0.242,无统计学显著差异。
  • 术后早期PBC组面部麻木、干眼症状及咀嚼肌无力发生率均显著高于MVD组(p均<0.05)。
  • MVD组开颅相关不良事件包括颅内感染(4.7%)、脑脊液漏(3.1%)及切口感染(3.1%),颅神经并发症包括复视(3.1%)、面瘫(1.6%)、听力下降(7.8%)及耳鸣(9.4%)。
  • 末次随访PBC组BNI麻木评分显著高于MVD组(p=0.001);PBC组术后住院时间更短、住院费用更低(p<0.001)。

关键数值与推荐

  • 疼痛控制采用BNI评分系统,初始控制优定义为BNI疼痛评分I或II。
  • 复发定义为BNI疼痛评分III、IV或V。
  • 末次随访复发率MVD组12.5%(8/64)、PBC组20.9%(9/43),p=0.242。
  • 早期三叉神经功能障碍各指标PBC组高于MVD组,p均<0.05。
  • 末次随访BNI麻木评分PBC组高于MVD组,p=0.001;住院时间与费用PBC组低于MVD组,p<0.001。

临床怎么用

  • VBD-TN患者选择术式时需权衡:MVD住院资源消耗更高、颅神经并发症更多样,PBC长期面部麻木更突出。
  • 两组复发率无统计学显著差异,可结合患者对麻木耐受度与手术风险偏好个体化决策。
  • MVD组开颅相关并发症(颅内感染、脑脊液漏、切口感染)及颅神经并发症需在围手术期重点监测与处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Trigeminal neuralgia secondary to vertebrobasilar dolichoectasia (VBD-TN) poses a significant challenge in the surgical management of trigeminal neuralgia. This study aimed to evaluate and compare the therapeutic efficacy of microvascular decompression (MVD) and percutaneous balloon compression (PBC) in patients with VBD-TN. METHODS: We conducted a retrospective cohort analysis of consecutive VBD-TN patients treated at a tertiary hospital in China between September 2013 and August 2022. Participants were stratified by the intervention (MVD vs PBC), with systematic evaluation of postoperative pain control efficacy and complication rates. RESULTS: This study enrolled 107 patients with VBD-TN, with a mean age of 64.8 ± 10.0 years and a mean follow-up duration of 3.9 ± 1.9 years. The cohort comprised 64 patients undergoing MVD and 43 receiving PBC. Both groups achieved excellent initial pain control (The Barrow Neurological Institute scoring system (BNI) pain score I or II). The recurrence (BNI Ⅲ, Ⅳ, Ⅴ) rates were 12.5% (8/64) in the MVD group versus 20.9% (9/43) in the PBC group (p = 0.242) at the last follow-up, showing no statistically significant difference. Early postoperative assessment revealed significantly higher incidences of trigeminal dysfunction including facial numbness, dry eye symptoms, and masticatory muscle weakness in the PBC group compared to the MVD group (p < 0.05 for all). Conversely, the MVD group demonstrated more diverse complications, with craniotomy-related adverse events including intracranial infection (4.7%), cerebrospinal fluid leakage (3.1%), and incision infection (3.1%), while cranial nerve complications comprised diplopia (3.1%), facial palsy (1.6%), hearing loss (7.8%), and tinnitus (9.4%). At the final follow-up, the PBC group exhibited significantly higher BNI numbness scores than the MVD group (p = 0.001). The PBC group showed advantages in healthcare utilization metrics, with significantly shorter postoperative hospital stays and lower hospitalization costs compared to the MVD group (p < 0.001). CONCLUSIONS: Both MVD and PBC are safe and effective therapeutic options for VBD-TN. MVD is associated with higher hospitalization costs, prolonged hospital stays, and a greater incidence of cranial nerve complications, though most of these complications are treatable. The main disadvantage of PBC lies in the long-term facial numbness.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Gao Z, Liu R, Lin P, et al. Efficacy analysis of microvascular decompression and percutaneous balloon compression for trigeminal neuralgia secondary to vertebrobasilar dolichoectasia: a retrospective cohort study. Acta Neurochir (Wien). 2025. PMID: 40836140. doi:10.1007/s00701-025-06651-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。